相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma
Katharina Leuchte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators
Oliver E. Amin et al.
HEPATOLOGY (2021)
Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
Jiri Eitler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
CD6 is a target for cancer immunotherapy
Jeffrey H. Ruth et al.
JCI INSIGHT (2021)
Toward a new landscape for the mechanism of immunosuppression in hepatocellular carcinoma
Chien-Wei Su et al.
HEPATOLOGY INTERNATIONAL (2021)
Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
Byung Min Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion
Marie Marotel et al.
ELIFE (2021)
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
Alessandra Zecca et al.
CELLS (2021)
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B
Greta Acerbi et al.
JOURNAL OF HEPATOLOGY (2021)
TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
Zhouhong Ge et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling
Siyu Tan et al.
CANCER RESEARCH (2020)
Identification of an HLA-A*24:02-restricted alpha-fetoprotein signal peptide-derived antigen and its specific T-cell receptor for T-cell immunotherapy
Zhenjuan Li et al.
IMMUNOLOGY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targeting p53 and histone methyltransferases restores exhausted CD8+T cells in HCV infection
Valeria Barili et al.
NATURE COMMUNICATIONS (2020)
Human Liver Memory CD8+ T Cells Use Autophagy for Tissue Residence
Leo Swadling et al.
CELL REPORTS (2020)
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma
Alessandra Zecca et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
Stefania Mantovani et al.
CANCERS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Le Qin et al.
BIOMARKER RESEARCH (2020)
Regulatory T cell and activated natural killer cell infiltration in hepatocellular carcinoma: immune cell profiling using the CIBERSORT
Lixin Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Mucosal-Associated Invariant T cell in liver diseases
Yujue Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
Hye Won Lee et al.
IMMUNE NETWORK (2020)
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
Jeong-Hoon Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma
Stefania Mantovani et al.
HEPATOLOGY (2019)
Immunotherapy: Current Status and Future Perspectives
Charalampos S. Floudas et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Treatment Strategies for Hepatocellular CarcinomaA Multidisciplinary Approach
Isabella Lurje et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells
Shin Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Takahiro Kamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Immune cell therapy for hepatocellular carcinoma
Eishiro Mizukoshi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular Carcinoma
Ying Liu et al.
JOURNAL OF IMMUNOLOGY (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+T cell responses
Amare Aregay et al.
JOURNAL OF HEPATOLOGY (2019)
Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma
Haoyu Sun et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology
Joanna Mikulak et al.
FRONTIERS IN IMMUNOLOGY (2019)
The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review
Sarun Juengpanich et al.
TRANSLATIONAL ONCOLOGY (2019)
Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells
Bin Sun et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Chimeric antigen receptor modified T cell (CAR-T) co-expressed with ICOSL-41BB promote CAR-T proliferation and tumor rejection
Wei Hu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy
Paola Fisicaro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
Alexandre P. Benechet et al.
NATURE (2019)
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Xiaohu Zheng et al.
NATURE IMMUNOLOGY (2019)
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Mariya Lazarova et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma
Haoyu Sun et al.
HEPATOLOGY (2019)
NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection
Anita Schuch et al.
JOURNAL OF HEPATOLOGY (2019)
Lactate-Mediated Acidification of Tumor Microenvironment Induces Apoptosis of Liver-Resident NK Cells in Colorectal Liver Metastasis
Cathal Harmon et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Chimeric antigen receptor-engineered T-cell therapy for liver cancer
Yang Chen et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
Identification of -fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
Wei Zhu et al.
HEPATOLOGY (2018)
Immune Responses in the Liver
Paul Kubes et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis
Julia Pollmann et al.
JOURNAL OF HEPATOLOGY (2018)
CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients
Motonobu Nomura et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
Min Yu et al.
MOLECULAR THERAPY (2018)
IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
Nicholas J. W. Easom et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
Faezeh Hosseinzadeh et al.
CANCER CELL INTERNATIONAL (2018)
Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome
Mohammed Alnaggar et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
Pingyi Liu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim et al.
GASTROENTEROLOGY (2018)
Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications
Pil Soo Sung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Natural killer cells might adapt their inhibitory receptors for memory
Megan A. Cooper
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
Xingliang Guo et al.
FRONTIERS IN PHARMACOLOGY (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies
Paulina Nowakowska et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
Cheng Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CART-Cell Therapy for Liver Cancer
Hong Liu et al.
CLINICAL CANCER RESEARCH (2017)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Austin G. Duffy et al.
JOURNAL OF HEPATOLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
Paola Fisicaro et al.
NATURE MEDICINE (2017)
Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer
Mao Lin et al.
ONCOTARGET (2017)
Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma
Kiichiro Kaji et al.
PLOS ONE (2017)
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+hepatocellular carcinoma (r/r GPC3+HCC).
Bo Zhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Novel treatments for chronic hepatitis C: closing the remaining gaps
Naim Alkhouri et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
Longhao Sun et al.
TUMOR BIOLOGY (2016)
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy
Suresh Gopi Kalathil et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Immunology in the liver - from homeostasis to disease
Felix Heymann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host
Anna Schurich et al.
Cell Reports (2016)
Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
Takahiro Kamiya et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Regulation of Natural Killer Cell Function by STAT3
Nicholas A. Cacalano
FRONTIERS IN IMMUNOLOGY (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
PD-1+ and Foxp3+ T cell reduction correlates with survival of HCC patients after sorafenib therapy
Suresh Gopi Kalathil et al.
JCI INSIGHT (2016)
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun et al.
ACTA PHARMACOLOGICA SINICA (2015)
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
Gaixia He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
Waseem Qasim et al.
JOURNAL OF HEPATOLOGY (2015)
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
Stephen Locarnini et al.
JOURNAL OF HEPATOLOGY (2015)
The yin and yang of evasion and immune activation in HCC
Oxana V. Makarova-Rusher et al.
JOURNAL OF HEPATOLOGY (2015)
The evolving epidemiology of hepatocellular carcinoma: a global perspective
Michael C. Wallace et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
Natural Killer Cells in Viral Hepatitis
Barbara Rehermann
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Balancing natural killer cell activation through paired receptors
Ludovic Martinet et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
Huiping Gao et al.
CLINICAL CANCER RESEARCH (2014)
UPR decreases CD226 ligand CD155 expression and sensitivity to NK cell-mediated cytotoxicity in hepatoma cells
Jiuyu Gong et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Immunodominance and Functional Alterations of Tumor-Associated Antigen-Specific CD8+ T-Cell Responses in Hepatocellular Carcinoma
Tobias Flecken et al.
HEPATOLOGY (2014)
Protective immunity against hepatitis C: many shades of gray
Mohamed S. Abdel-Hakeem et al.
FRONTIERS IN IMMUNOLOGY (2014)
Are natural killer cells superior CAR drivers?
Hans Klingemann
ONCOIMMUNOLOGY (2014)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2013)
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion
Dimitra Peppa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Persistent hepatitis C virus (HCV) infection impairs HCV-specific cytotoxic T cell reactivity through Mcl-1/Bim imbalance due to CD127 down-regulation
J. R. Larrubia et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Barbara Rehermann
NATURE MEDICINE (2013)
The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
Anna Schurich et al.
PLOS PATHOGENS (2013)
T-cell responses in hepatitis B and C virus infection: similarities and differences
Julia Schmidt et al.
EMERGING MICROBES & INFECTIONS (2013)
Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma
Yunhong Xia et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
Arthur Y. Kim et al.
GASTROENTEROLOGY (2011)
Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection
Karen Fitzmaurice et al.
GUT (2011)
Comparative Analysis of Various Tumor-Associated Antigen-Specific T-Cell Responses in Patients with Hepatocellular Carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2011)
Activating and inhibitory receptors of natural killer cells
Hollie J. Pegram et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-γ on activation
Andrea De Maria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment
Omar Dessouki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus
Barbara Amadei et al.
GASTROENTEROLOGY (2010)
Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity
Rachel H. McMahan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Natural Killer Cell Functional Dichotomy in Chronic Hepatitis B and Chronic Hepatitis C Virus Infections
Barbara Oliviero et al.
GASTROENTEROLOGY (2009)
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response
Eva Dazert et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Macrophages in Hepatitis B and Hepatitis C Virus Infections
Mathis Heydtmann
JOURNAL OF VIROLOGY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587
Qiao Xing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Comprehensive Analysis of the α-Fetoprotein-Specific CD8+ T Cell Responses in Patients with Hepatocellular Carcinoma
Robert Thimme et al.
HEPATOLOGY (2008)
Bim-mediated deletion of anti gen-specific CD8+ T cells in patients unable to control HBV infection
A. Ross Lopes et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Hepatitis C Virus Immune Escape via Exploitation of a Hole in the T Cell Repertoire
Matthias Woelfl et al.
JOURNAL OF IMMUNOLOGY (2008)
Natural killer cell recognition of missing self
Klas Karre
NATURE IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor β that can suppress HCV-specific T-cell responses
Nadia Alatrakchi et al.
JOURNAL OF VIROLOGY (2007)
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
Claire Dunn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection
Amalia Penna et al.
HEPATOLOGY (2007)
Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression
Henry Radziewicz et al.
JOURNAL OF VIROLOGY (2007)
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2006)
Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C
J Nattermann et al.
GUT (2006)
Identification of HLA-A2-or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma
H Komori et al.
CLINICAL CANCER RESEARCH (2006)
Identification of α-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+patients with hepatocellular carcinoma
E Mizukoshi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma
G Bricard et al.
JOURNAL OF IMMUNOLOGY (2005)
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma
F Korangy et al.
CLINICAL CANCER RESEARCH (2004)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
T Takayama et al.
LANCET (2000)
Analysis of successful immune responses in persons infected with hepatitis C virus
F Lechner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
